STMND1
gene geneOn this page
Also known as FLJ23152
Summary
STMND1 (stathmin domain containing 1, HGNC:44668) is a protein-coding gene on chromosome 6p22.3, encoding Stathmin domain-containing protein 1 (H3BQB6).
Predicted to be involved in regulation of microtubule polymerization or depolymerization.
Source: NCBI Gene 401236 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_001190766
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44668 |
| Approved symbol | STMND1 |
| Name | stathmin domain containing 1 |
| Location | 6p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23152 |
| Ensembl gene | ENSG00000230873 |
| Ensembl biotype | protein_coding |
| Entrez | 401236 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000354384, ENST00000366215, ENST00000536551, ENST00000907738
RefSeq mRNA: 1 — MANE Select: NM_001190766
NM_001190766
CCDS: CCDS58997
Canonical transcript exons
ENST00000536551 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002266322 | 17129112 | 17129243 |
| ENSE00002279270 | 17120607 | 17120758 |
| ENSE00002284098 | 17114962 | 17115139 |
| ENSE00002305699 | 17102050 | 17102338 |
| ENSE00003517930 | 17130594 | 17131378 |
Expression profiles
Bgee: expression breadth broad, 75 present calls, max score 91.37.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0576 / max 14.8412, expressed in 30 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66120 | 0.0389 | 18 |
| 66119 | 0.0187 | 8 |
Top tissues by expression
108 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 91.37 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.81 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.64 | gold quality |
| gall bladder | UBERON:0002110 | 73.45 | gold quality |
| fallopian tube | UBERON:0003889 | 72.65 | gold quality |
| body of pancreas | UBERON:0001150 | 72.47 | gold quality |
| testis | UBERON:0000473 | 69.15 | gold quality |
| right testis | UBERON:0004534 | 68.35 | gold quality |
| left testis | UBERON:0004533 | 68.25 | gold quality |
| right lung | UBERON:0002167 | 66.23 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.97 | gold quality |
| pancreas | UBERON:0001264 | 64.41 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 62.92 | gold quality |
| endometrium | UBERON:0001295 | 62.19 | gold quality |
| rectum | UBERON:0001052 | 58.06 | gold quality |
| transverse colon | UBERON:0001157 | 56.00 | gold quality |
| lung | UBERON:0002048 | 55.54 | gold quality |
| left uterine tube | UBERON:0001303 | 53.77 | gold quality |
| stromal cell of endometrium | CL:0002255 | 51.71 | silver quality |
| upper lobe of left lung | UBERON:0008952 | 51.36 | gold quality |
| duodenum | UBERON:0002114 | 51.09 | gold quality |
| pituitary gland | UBERON:0000007 | 50.23 | gold quality |
| adenohypophysis | UBERON:0002196 | 50.09 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.87 | gold quality |
| colon | UBERON:0001155 | 48.83 | gold quality |
| hypothalamus | UBERON:0001898 | 47.47 | gold quality |
| colonic epithelium | UBERON:0000397 | 47.06 | gold quality |
| endocervix | UBERON:0000458 | 46.65 | gold quality |
| prefrontal cortex | UBERON:0000451 | 46.02 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 45.99 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting STMND1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-124-3P | 99.89 | 73.74 | 3043 |
| HSA-MIR-506-3P | 99.89 | 73.55 | 3057 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-5003-5P | 99.61 | 69.13 | 1624 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
| HSA-MIR-1909-5P | 98.94 | 64.01 | 484 |
| HSA-MIR-5581-3P | 98.55 | 70.31 | 1161 |
| HSA-MIR-7843-3P | 98.31 | 67.94 | 803 |
| HSA-MIR-876-5P | 97.99 | 68.49 | 1345 |
Literature-anchored findings (GeneRIF, showing 1)
- STMND1 is a phylogenetically ancient stathmin which localizes to motile cilia and exhibits nuclear translocation that is inhibited when soluble tubulin concentration increases. (PMID:38630521)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | stmnd1 | ENSDARG00000102611 |
| mus_musculus | Stmnd1 | ENSMUSG00000063529 |
| rattus_norvegicus | Stmnd1 | ENSRNOG00000031595 |
| drosophila_melanogaster | stai | FBGN0266521 |
Paralogs (4): STMN4 (ENSG00000015592), STMN2 (ENSG00000104435), STMN1 (ENSG00000117632), STMN3 (ENSG00000197457)
Protein
Protein identifiers
Stathmin domain-containing protein 1 — H3BQB6 (reviewed: H3BQB6)
All UniProt accessions (2): H3BQB6, H3BMF7
RefSeq proteins (1): NP_001177695* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000956 | Stathmin_fam | Family |
| IPR036002 | Stathmin_sf | Homologous_superfamily |
Pfam: PF00836
UniProt features (9 total): region of interest 3, compositionally biased region 2, initiator methionine 1, chain 1, domain 1, lipid moiety-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-H3BQB6-F1 | 63.83 | 0.15 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOBP_NEUROGENESIS, GOBP_MICROTUBULE_DEPOLYMERIZATION, GOBP_PROTEIN_DEPOLYMERIZATION, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, GOMF_CYTOSKELETAL_PROTEIN_BINDING, GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION, GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY, LEE_BMP2_TARGETS_UP, GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION, CBX7_TARGET_GENES, RYBP_TARGET_GENES
GO Biological Process (1): regulation of microtubule polymerization or depolymerization (GO:0031110)
GO Molecular Function (0):
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| microtubule polymerization or depolymerization | 1 |
| regulation of microtubule cytoskeleton organization | 1 |
Protein interactions and networks
STRING
146 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STMND1 | KIF13A | Q9H1H9 | 646 |
| STMND1 | ATXN1 | P54253 | 595 |
| STMND1 | RBM24 | Q9BX46 | 570 |
| STMND1 | SMOC2 | Q9H3U7 | 512 |
| STMND1 | FAM8A1 | Q9UBU6 | 474 |
| STMND1 | MYLIP | Q8WY64 | 473 |
| STMND1 | ATXN1L | P0C7T5 | 458 |
| STMND1 | SYNDIG1L | A6NDD5 | 447 |
| STMND1 | MRGPRE | Q86SM8 | 418 |
| STMND1 | TBC1D16 | Q8TBP0 | 396 |
| STMND1 | NHLRC1 | Q6VVB1 | 381 |
| STMND1 | TBC1D17 | Q9HA65 | 370 |
| STMND1 | GMPR | P36959 | 366 |
| STMND1 | MAP3K6 | O95382 | 305 |
| STMND1 | JARID2 | Q92833 | 295 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2CE83, A5D8S8, A5WUN7, D4AEC2, H3BQB6, O35867, O75167, O94885, P28290, P59808, P62025, Q08AD1, Q28GJ0, Q2MJV9, Q3KQW7, Q3KR53, Q3MHH7, Q3TRR0, Q3UH68, Q4KM62, Q4R6Q9, Q4R707, Q52KF3, Q5NVK0, Q5RC32, Q5RHU7, Q5TID7, Q63HQ0, Q69ZW3, Q6AYN9, Q6GLU8, Q6IRN6, Q6P3A1, Q6RFY2, Q7ZX27, Q80ZU5, Q86VQ0, Q8BYK5, Q8C1B1, Q8HYW0
Diamond homologs: H3BQB6, Q6P3A1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1092 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:17102336:AAG:A | donor_loss | 1.0000 |
| 6:17102337:AGGT:A | donor_loss | 1.0000 |
| 6:17102339:G:GA | donor_loss | 1.0000 |
| 6:17114957:CACA:C | acceptor_loss | 1.0000 |
| 6:17114958:A:AG | acceptor_gain | 1.0000 |
| 6:17114958:ACAG:A | acceptor_gain | 1.0000 |
| 6:17114959:C:G | acceptor_gain | 1.0000 |
| 6:17114959:CA:C | acceptor_loss | 1.0000 |
| 6:17114960:A:AC | acceptor_loss | 1.0000 |
| 6:17114960:A:AG | acceptor_gain | 1.0000 |
| 6:17114960:AG:A | acceptor_gain | 1.0000 |
| 6:17114960:AGGCT:A | acceptor_gain | 1.0000 |
| 6:17114961:G:GG | acceptor_gain | 1.0000 |
| 6:17114961:GG:G | acceptor_gain | 1.0000 |
| 6:17114961:GGC:G | acceptor_gain | 1.0000 |
| 6:17114961:GGCT:G | acceptor_gain | 1.0000 |
| 6:17114961:GGCTG:G | acceptor_gain | 1.0000 |
| 6:17115125:GACGA:G | donor_gain | 1.0000 |
| 6:17115136:TCAG:T | donor_loss | 1.0000 |
| 6:17115137:CAG:C | donor_loss | 1.0000 |
| 6:17115138:AG:A | donor_loss | 1.0000 |
| 6:17115139:GG:G | donor_loss | 1.0000 |
| 6:17115140:GT:G | donor_loss | 1.0000 |
| 6:17115141:T:A | donor_loss | 1.0000 |
| 6:17120601:T:TA | acceptor_gain | 1.0000 |
| 6:17120602:G:A | acceptor_gain | 1.0000 |
| 6:17120703:G:GT | donor_gain | 1.0000 |
| 6:17129110:A:AG | acceptor_gain | 1.0000 |
| 6:17129111:G:GA | acceptor_gain | 1.0000 |
| 6:17129111:GTT:G | acceptor_gain | 1.0000 |
AlphaMissense
1800 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:17120691:T:C | L115P | 0.989 |
| 6:17120706:T:C | I120T | 0.969 |
| 6:17120691:T:A | L115Q | 0.968 |
| 6:17120703:G:T | G119V | 0.963 |
| 6:17120679:T:C | I111T | 0.958 |
| 6:17120679:T:G | I111S | 0.957 |
| 6:17120706:T:G | I120S | 0.957 |
| 6:17120709:T:A | I121K | 0.949 |
| 6:17120702:G:A | G119R | 0.937 |
| 6:17120702:G:C | G119R | 0.937 |
| 6:17120709:T:C | I121T | 0.933 |
| 6:17120691:T:G | L115R | 0.927 |
| 6:17120679:T:A | I111N | 0.907 |
| 6:17120709:T:G | I121R | 0.905 |
| 6:17129155:T:C | L152P | 0.904 |
| 6:17120700:A:C | Q118P | 0.886 |
| 6:17120703:G:C | G119A | 0.886 |
| 6:17120703:G:A | G119E | 0.885 |
| 6:17120682:T:C | L112P | 0.875 |
| 6:17120706:T:A | I120N | 0.870 |
| 6:17129153:A:C | R151S | 0.868 |
| 6:17129153:A:T | R151S | 0.868 |
| 6:17130840:T:C | S264P | 0.860 |
| 6:17120688:A:T | E114V | 0.857 |
| 6:17120701:A:C | Q118H | 0.829 |
| 6:17120701:A:T | Q118H | 0.829 |
| 6:17102261:G:C | G2R | 0.820 |
| 6:17120685:A:T | E113V | 0.820 |
| 6:17130857:C:A | N269K | 0.808 |
| 6:17130857:C:G | N269K | 0.808 |
dbSNP variants (sampled 300 via entrez): RS1000025158 (6:17110649 C>G,T), RS1000077463 (6:17110981 T>A,C), RS1000345103 (6:17104797 T>C), RS1000509181 (6:17102814 A>G), RS1000616400 (6:17110967 G>A,C), RS1000772351 (6:17100125 C>T), RS1000782052 (6:17100135 T>A,G), RS1000811678 (6:17103111 T>C), RS1000945720 (6:17129938 T>C), RS1000977998 (6:17116773 A>C,G), RS1000981451 (6:17122070 C>T), RS1001008189 (6:17115164 C>T), RS1001064316 (6:17109499 A>T), RS1001116496 (6:17130090 G>A), RS1001398962 (6:17130411 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005316_635 | Intelligence (MTAG) | 5.000000e-09 |
| GCST005316_636 | Intelligence (MTAG) | 3.000000e-09 |
| GCST007433_3 | Fulminant type 1 diabetes | 6.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.